27-Hydroxycholesterol contributes to cognitive deficits in APP/PS1 transgenic mice through microbiota dysbiosis and intestinal barrier dysfunction

[1]  Jia-Yi Li,et al.  Microbiome changes: an indicator of Parkinson’s disease? , 2019, Translational Neurodegeneration.

[2]  P. Strappe,et al.  Abundance of Probiotics and Butyrate-Production Microbiome Manages Constipation Via Short-Chain Fatty Acids Production and Hormones Secretion. , 2019, Molecular nutrition & food research.

[3]  K. Korach,et al.  27-Hydroxycholesterol Promotes Adiposity and Mimics Adipogenic Diet-induced Inflammatory Signaling. , 2019, Endocrinology.

[4]  Tianyu Gong,et al.  Fecal microbiota transplantation alleviated Alzheimer’s disease-like pathogenesis in APP/PS1 transgenic mice , 2019, Translational Psychiatry.

[5]  Dandan Wu,et al.  Candesartan attenuates hypertension-associated pathophysiological alterations in the gut. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[6]  D. Hervás,et al.  Neuropsychological assessment and cortisol levels in biofluids from early Alzheimer's disease patients , 2019, Experimental Gerontology.

[7]  Lanjuan Li,et al.  Altered microbiomes distinguish Alzheimer’s disease from amnestic mild cognitive impairment and health in a Chinese cohort , 2019, Brain, Behavior, and Immunity.

[8]  M. Nair,et al.  Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics , 2019, International journal of nanomedicine.

[9]  Qiang Xu,et al.  Dietary fructose-induced gut dysbiosis promotes mouse hippocampal neuroinflammation: a benefit of short-chain fatty acids , 2019, Microbiome.

[10]  H. Griffiths,et al.  Increased production of 27‐hydroxycholesterol in human colorectal cancer advanced stage: Possible contribution to cancer cell survival and infiltration , 2019, Free radical biology & medicine.

[11]  Lei Zhao,et al.  NF‐κB‐mediated inflammatory damage is differentially affected in SH‐SY5Y and C6 cells treated with 27‐hydroxycholesterol , 2019, Food science & nutrition.

[12]  A. Minihane,et al.  APOE genotype influences the gut microbiome structure and function in humans and mice: relevance for Alzheimer’s disease pathophysiology , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  P. Svenningsson,et al.  On the fluxes of side-chain oxidized oxysterols across blood-brain and blood-CSF barriers and origin of these steroids in CSF (Review) , 2019, The Journal of Steroid Biochemistry and Molecular Biology.

[14]  R. Xiao,et al.  27-Hydroxycholesterol Alters Synaptic Structural and Functional Plasticity in Hippocampal Neuronal Cultures , 2019, Journal of neuropathology and experimental neurology.

[15]  R. Xiao,et al.  27-Hydroxycholesterol Contributes to Lysosomal Membrane Permeabilization-Mediated Pyroptosis in Co-cultured SH-SY5Y Cells and C6 Cells , 2019, Front. Mol. Neurosci..

[16]  T. Willinger.  Oxysterols in intestinal immunity and inflammation , 2018, Journal of internal medicine.

[17]  Tao Wang,et al.  27‐hydroxycholesterol promotes Aβ accumulation via altering Aβ metabolism in mild cognitive impairment patients and APP/PS1 mice , 2019, Brain pathology.

[18]  T. Dinan,et al.  The Neuroendocrinology of the Microbiota-Gut-Brain Axis: A Behavioural Perspective , 2018, Frontiers in Neuroendocrinology.

[19]  Ren Yan,et al.  Butyrate Protects Mice Against Methionine–Choline-Deficient Diet-Induced Non-alcoholic Steatohepatitis by Improving Gut Barrier Function, Attenuating Inflammation and Reducing Endotoxin Levels , 2018, Front. Microbiol..

[20]  A. Hartikainen,et al.  The Potential of Gut Commensals in Reinforcing Intestinal Barrier Function and Alleviating Inflammation , 2018, Nutrients.

[21]  J. Viña,et al.  Shifts in gut microbiota composition in an APP/PSS1 transgenic mouse model of Alzheimer's disease during lifespan , 2018, Letters in applied microbiology.

[22]  M. Staufenbiel,et al.  Innate immune memory in the brain shapes neurological disease hallmarks , 2018, Nature.

[23]  C. Lv,et al.  Increased Levels of 27‐Hydroxycholesterol Induced by Dietary Cholesterol in Brain Contribute to Learning and Memory Impairment in Rats , 2018, Molecular nutrition & food research.

[24]  P. Gean,et al.  Impact of social relationships on Alzheimer’s memory impairment: mechanistic studies , 2018, Journal of Biomedical Science.

[25]  X. Jing,et al.  Curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide for potential use in Alzheimer’s disease , 2018, Drug delivery.

[26]  E. Nelson.  The significance of cholesterol and its metabolite, 27-hydroxycholesterol in breast cancer , 2017, Molecular and Cellular Endocrinology.

[27]  R. Loi,et al.  Derangement of intestinal epithelial cell monolayer by dietary cholesterol oxidation products , 2017, Free radical biology & medicine.

[28]  Yanlin Chen,et al.  Liraglutide Improves Water Maze Learning and Memory Performance While Reduces Hyperphosphorylation of Tau and Neurofilaments in APP/PS1/Tau Triple Transgenic Mice , 2017, Neurochemical Research.

[29]  Lanjuan Li,et al.  Influences of the Gut Microbiota on DNA Methylation and Histone Modification , 2017, Digestive Diseases and Sciences.

[30]  T. Dinan,et al.  Targeting the Microbiota-Gut-Brain Axis: Prebiotics Have Anxiolytic and Antidepressant-like Effects and Reverse the Impact of Chronic Stress in Mice , 2017, Biological Psychiatry.

[31]  G. Frisoni,et al.  Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly , 2017, Neurobiology of Aging.

[32]  Liang Shen,et al.  Alzheimer's Disease Histological and Behavioral Manifestations in Transgenic Mice Correlate with Specific Gut Microbiome State. , 2017, Journal of Alzheimer's disease : JAD.

[33]  B. Schreurs,et al.  A High-Cholesterol Diet Increases 27-Hydroxycholesterol and Modifies Estrogen Receptor Expression and Neurodegeneration in Rabbit Hippocampus. , 2017, Journal of Alzheimer's disease : JAD.

[34]  R. Xiao,et al.  Relationship between oxysterols and mild cognitive impairment in the elderly: a case–control study , 2016, Lipids in Health and Disease.

[35]  G. Muccioli,et al.  Oxysterols: From cholesterol metabolites to key mediators. , 2016, Progress in lipid research.

[36]  A. Jačan,et al.  Cognitive impairment by antibiotic-induced gut dysbiosis: Analysis of gut microbiota-brain communication , 2016, Brain, Behavior, and Immunity.

[37]  J. Dahlerup,et al.  Effects of Arabinoxylan and Resistant Starch on Intestinal Microbiota and Short-Chain Fatty Acids in Subjects with Metabolic Syndrome: A Randomised Crossover Study , 2016, PloS one.

[38]  G. Muccioli,et al.  Oxysterols in Metabolic Syndrome: From Bystander Molecules to Bioactive Lipids. , 2016, Trends in molecular medicine.

[39]  H. Sokol,et al.  Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic mice , 2015, The ISME Journal.

[40]  I. Pikuleva,et al.  Marketed Drugs Can Inhibit Cytochrome P450 27A1, a Potential New Target for Breast Cancer Adjuvant Therapy , 2015, Molecular Pharmacology.

[41]  Q. Liu,et al.  27-Hydroxycholesterol contributes to disruptive effects on learning and memory by modulating cholesterol metabolism in the rat brain , 2015, Neuroscience.

[42]  O. Ghribi,et al.  Does the oxysterol 27-hydroxycholesterol underlie Alzheimer's disease–Parkinson's disease overlap? , 2015, Experimental Gerontology.

[43]  W. Lukiw,et al.  Microbiome-generated amyloid and potential impact on amyloidogenesis in Alzheimer's disease (AD). , 2015, Journal of nature and science.

[44]  B. Winblad,et al.  27-Hydroxycholesterol mediates negative effects of dietary cholesterol on cognition in mice , 2015, Behavioural Brain Research.

[45]  M. Borowiec,et al.  The effect of oxidized cholesterol on barrier functions and IL-10 mRNA expression in human intestinal epithelium co-cultured with dendritic cells in the transwell system. , 2014, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[46]  M. Lynch,et al.  Age-associated dysregulation of microglial activation is coupled with enhanced blood-brain barrier permeability and pathology in APP/PS1 mice , 2014, Neurobiology of Aging.

[47]  D. Sinderen,et al.  Gut microbiota composition correlates with diet and health in the elderly , 2012, Nature.

[48]  H. Flint,et al.  Oligonucleotide Probes That Detect Quantitatively Significant Groups of Butyrate-Producing Bacteria in Human Feces , 2003, Applied and Environmental Microbiology.

[49]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[50]  J Tuomilehto,et al.  Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study , 2001, BMJ.

[51]  Andrew J. Brown,et al.  Oxysterols and atherosclerosis. , 1999, Atherosclerosis.

[52]  Allan I. Levey,et al.  Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo , 1996, Neuron.